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Rickettsia prowazekii is the causative agent of epidem-
ic typhus and a potential bioterrorism agent. Sensitive and
specific rapid assays are needed to complement existing
methods of detecting this organism. We developed a real-
time quantitative polymerase chain reaction assay by using
a species-specific probe targeting the gltA gene. This
assay, which was rapid, specific for R. prowazekii only, and
sensitive (cutoff detection of 1 to 5 copies per sample),
detected and directly identified R. prowazekii in blood of 12
experimentally infected mice sampled at day 3 and 6
postinfection or in naturally or experimentally infected lice.
Because our assay is highly standardized and easily adapt-
able, it could improve epidemic typhus surveillance in pub-
lic health programs, especially for countries with
underdiagnosed or unrecognized human cases.
R
ickettsia prowazekii is the causative agent of epidemic
or louseborne typhus, which is transmitted by the
human body louse. This disease can be fatal and, without
treatment with doxycycline, will cause death in up to 30%
of cases (1–3). More than 30 million cases of epidemic
typhus occurred during and immediately after World War
I, resulting in an estimated 3 million deaths (1). Although
the incidence of epidemic typhus is low today, the infec-
tion could reemerge in epidemic form in human popula-
tions, as recently reported in Burundi (4), Russia (5), and
Algeria (6). Infections with R. prowazekii have been rarely
reported in the United States: only 39 cases were reported
from 1976 to 2001, all in persons who had no reported con-
tact with body lice but did have contact with flying squir-
rels (7,8). 
The ability to be acquired by the aerosol route, efficient
arthropod transmission, and severe clinical outcome and
death in untreated cases make R. prowazekii a category B
bioterrorism agent. The former Soviet Union’s Red Army
developed R. prowazekii as a battlefield weapon, and the
Japanese army successfully tested bombs containing the
pathogen (9).
Since clinical signs of epidemic typhus are usually non-
specific, including fever, headaches, and severe myalgia,
appropriate diagnostic methods are important (10). Despite
recent developments in cell culture and molecular detec-
tion methods for the diagnosis of rickettsial diseases (11),
serologic assays remain the simplest diagnostic tests to
perform, even if serum samples are sent on filter paper
(12). Nevertheless, serologic tests lack specificity because
most also detect cross-reactive antibodies among the
typhus-group rickettsioses. Moreover, a definite diagnosis
of epidemic typhus is often delayed because the sensitivi-
ty of cell culture and polymerase chain reaction (PCR)
methods is low (13), and serologic diagnosis can be
obtained only by using advanced serologic methods such
as Western blot analysis after cross-adsorptions. These
methods are restricted to laboratories with biosafety level
3 (BSL-3) facilities and trained technicians (14). Recent
studies have demonstrated the usefulness of PCR of body
lice in ongoing surveillance of louse-associated infections,
especially in outbreaks of epidemic typhus (15). The aim
of our study was to develop a real-time quantitative PCR
assay by using a species-specific probe that is rapid, sensi-
tive, and specific for detecting R. prowazekii in clinical
samples or in body lice in outbreaks of epidemic typhus.
Materials and Methods
The  gltA sequences of 22 Rickettsia  species were
aligned by using the multiple-sequence alignment program
ClustalW supported by the Infobiogen website (www.info-
biogen.fr). Within the alignments, primers and probe were
selected that were specific for R. prowazekii. 
R. prowazekii strain Breinl (ATCC VR-142) was grown
in Vero cell monolayers cultured in minimal essential
medium supplemented with 4% fetal calf serum and 2
mmol/L L-glutamine as previously described (16).
Infected cells were harvested by using sterile glass beads
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gation, and the supernatant was centrifuged for 10 min at
7,500 × g. The resulting pellet was resuspended in 20 mL
phosphate-buffered saline, pH 7.5. R. prowazekii inoculum
was quantified by using either the plaque assay method
(17) or comparatively by 10-fold serial dilutions of a
known plasmid standard of R. prowazekii containing 2.0 ×
107 copies per sample in an independent real-time PCR as
previously described (18).
In this assay 4 R. prowazekii strains, 21 strains of
Rickettsia spp., and 14 strains of bacteria from genera
other than Rickettsia were evaluated (Table). We also
included 31 lice from an outbreak of epidemic typhus in
Rwanda in 2004 and 10 R. prowazekii laboratory-infected
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Borrelia recurrentis laboratory-infected lice (21). Finally,
we also included 30 lice received in June 2005 from
Rwanda, which were tested only with the quantitative PCR
(qPCR) assay (Table). Negative controls included 10
pathogen-free lice, distilled sterile water, and PCR mix-
ture. All experiments were repeated 4 times. For mice sam-
ples, DNA samples extracted from blood of uninfected
mice were used as negative controls.
We have also tested R. prowazekii–infected mice by
using a currently available experimental model similar to
the previous model described for R. typhi (22). We used 7-
week-old female BALB/C mice (Charles River
Laboratories, Arbresle, France) that were maintained in
cages with sterile food and water. All experiments were
performed in a BSL-3 laboratory. Twelve mice were inject-
ed with 1.8 × 105 PFU/mL R. prowazekii strain Breinl
(ATCC VR-142), and 6 mice were injected with uninfect-
ed cells. The solution containing bacteria was injected into
the retroorbital venous plexus over a period of 30 s. We
collected 200 µL of blood from each mouse at day 3
postinfection (PI) and at day 6 PI and stored it in EDTA at
–20°C for PCR.
Total genomic DNA from bacterial strains was extract-
ed with the Qiagen QIAamp Blood Kit (Qiagen, Hilden,
Germany), and lice DNA and blood and biopsy samples
from infected mice were extracted by using the Qiagen
QIAamp Tissue Protocol (Qiagen). PCR was performed by
using a LightCycler instrument (Roche Biochemicals,
Mannheim, Germany).The PCR mixture included a final
volume of 20 µL with 10 µL of the Probe Master kit
(Qiagen), 0.5 µL (10 pmol/µL) of each primer, 2 µL( 2
µmol/µL) probe, 5 µL distilled water, and 2 µL extracted
DNA. The amplification conditions were as follows: an
initial denaturation step at 95°C for 15 min, followed by 40
cycles of denaturation at 95°C, annealing and elongation at
60°C for 120 s, with fluorescence acquisition in single
mode. Each sample was also tested with a standard PCR
that was performed on a PCR instrument (Eppendorf,
Mastercycler, Hamburg, Germany) using primers of the
gltA gene (23). 
Results
The R. prowazekii inoculum used in this study was of
1.8 × 105 PFU/mL using the plaque assay quantification
method (17) and contained 1.16 × 106 copies per sample
when quantified with our plasmid standard (18). The
selected primers and probe of the gltA gene specific only
for  R. prowazekii were as follows: RproF (5′-TCG-
GTAAAGATGTAATCGATATAAG-3′), RproR (5′-
CATATCCTCGATACCATAATATGC-3′) and Rp.probe
(FAM-ACTTTACTTATGATCCGGGTTTTATG-
TAMRA), leading to a PCR product size of 154 bp. When
qPCR assay was used, only R. prowazekii strains were pos-
itive, whereas the standard PCR assay detected all rick-
ettsial species (Table). The standard PCR assay was
positive for all 20 laboratory-infected lice (R. typhi or R.
prowazekii), while qPCR assay was positive only for the
10 R. prowazekii laboratory-infected lice. Finally, blood
samples obtained from our experimental model of R.
prowazekii–infected mice at days 3 and 6 PI were also pos-
itive by using the protocol described above. The mean
number of cycle thresholds (Ct value) for mice sampled at
day 3 PI was 32.47 ± 2.11; at day 6 PI, the Ct value was of
35.52 ± 2.01 (p = 0.001). All uninfected lice, B. recurren-
tis–infected lice, and mice samples were negative with
both assays.
The sensitivity of qPCR and the standard PCR was
determined by using 10-fold serial dilutions of our known
R. prowazekii inoculum (1.16 × 106 DNA copies per sam-
ple). The sensitivity of the qPCR was increased 10-fold
over that of the standard PCR. Compared to our plasmid
standard, the cutoff detection of the qPCR was 1–5 copies
per sample, whereas the cutoff detection was >10 copies
for the standard PCR. 
Among the 31 lice from Rwanda sampled in 2004, 17
were positive by real-time PCR, whereas only 10 of these
17 lice were positive by standard PCR. The latter 10 sam-
ples had a mean number of 1,300 DNA copies (Ct value
26.82–35.22). The 7 samples positive only by real-time
PCR had a mean number of 8.5 DNA copies (Ct value
33.72–38.73). The real-time PCR therefore appears to be
more sensitive. However, this difference was not signifi-
cant (p = 0.07) perhaps because of the small number of
tested lice. Finally, 5 of the 30 lice received from Rwanda
in June 2005 were positive when the qPCR was used
(Table).
Discussion
We developed a real-time quantitative PCR for specific
detection of R. prowazekii. The selected primers and probe
were 100% complementary to R. prowazekii only and to no
other rickettsial strains. We confirmed the specificity of
these primers and probe on rickettsial isolates and other
common bacteria and repeated the experiments 4 times
without discrepancies. Real-time quantitative PCR for
rickettsiae was first developed to test antimicrobial drug
susceptibility (24) and then was used to detect R. rickettsii
and closely related spotted fever group rickettsiae (17) or
R. prowazekii strains (25).
Our assay has a greater sensitivity than the standard
assay, with a cut-off detection of only 1 to 5 DNA copies
per sample, as measured comparatively to plasmid DNA
quantification. The sensitivity found with our standard PCR
has been previously estimated at 1–10 DNA copies of the
gene (23). The first use of standard PCR for detecting
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gen sequence had a cut-off detection of as few as 30 rick-
ettsiae (26). Cutoff detection of rickettsiae with real-time
quantitative PCR ranges from 5 copies (17) to 10 copies
(25). Using our LightCycler assay, we detected an extra 7
samples in lice from Rwanda as compared to standard PCR.
Only 1 report exists of real-time detection of R. prowazekii
using molecular beacon probes targeting the ompB gene
(25). In this report, only 2 R. prowazekii strains were tested
(25). Moreover, we showed that R. prowazekii can be
amplified from blood of experimentally infected mice. This
experimental model of R. prowazekii infection and the abil-
ity to quantify the bacteria with the real-time PCR could be
used to better study the pathogenesis of the organism. We
found in this mouse model that the number of bacteria in
blood was lower at day 6 PI than that at day 3 PI, which
suggests that mice can eradicate infection at this dose.
The assay we describe can be performed wherever a
real-time quantitative PCR machine is available. The
reagents and the machine are standardized; this method
gives rapid results (sequencing is not necessary) and
decreases the likelihood of error. This assay was applied
successfully in lice received from Rwanda in June 2005.
Indeed, using our assay we were able to alert the World
Health Organization of the presence of R. prowazekii–pos-
itive lice within 1 working day. 
Because body lice and their associated diseases are gen-
erally encountered in areas where medical and biologic
assistance is limited, local assessment of their roles as
sources of infection is difficult. Lice are easy to collect and
to transport to reference laboratories, where suitable
molecular biologic approaches can be used (23). Although
sucking lice die within 24 h of their final blood meal, the
infecting bacterial DNA will remain intact for extraction
for several weeks if the samples are kept dry (15). Upon
arrival in the laboratory, the lice can be processed very
quickly, and a diagnosis can be established rapidly (DNA
extraction and LightCycler PCR take ≈5 h). Several weeks
are necessary to obtain bacterial culture and serologic
results, and those procedures do not always highlight the
presence of bacteria. The usefulness of bacterial DNA
detection in lice by PCR has been demonstrated by recent
investigations. In central Africa, large outbreaks of lice
infections occurred during civil wars in Burundi, Rwanda,
and Zaire and preceded the outbreak of epidemic typhus by
2 years (4). Finally, our data obtained in experimentally
infected mice suggest that real-time PCR could also be
useful for detecting R. prowazekii directly from blood
specimens. Because our assay is highly standardized and
easily adaptable anywhere and anytime, it could improve
epidemic typhus surveillance in public health programs,
especially for countries with underdiagnosed or unrecog-
nized human cases (4). 
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